Dietary Lactoferrin Does Not Prevent Dextran Sulfate Sodium Induced Murine Intestinal Lymphocyte Death

Abstract

Dextran sulfate sodium (DSS) induced intestinal inflammation is characterized by pronounced mucosal and epithelial cell damage. Bovine lactoferrin (bLf), a common dietary protein, influences inflammatory cytokines and intestinal lymphocyte (IL) apoptosis. The objectives of this study were to determine if 1) DSS induces IL necrotic or apoptotic death, 2) dietary bLf affects DSS induced IL death and 3) bLf alters cytokine profiles during DSS induced inflammation. Female C57BL/6 mice were randomized to 2% or 0% bLf diets for 12 d and within diets to 5% or 0% DSS in the drinking water for 4 d after which intestinal histology, IL number, IL apoptosis/necrosis, IL phenotypes, protein levels of pro-inflammatory cytokine (TNF-α) and transcription factor (NFκB), apoptotic (caspase 3, Bax) proteins, anti-inflammatory cytokine (IL-10) and anti-apoptotic (Bcl-2) protein in IL were evaluated. DSS treatment resulted in shortened intestinal length, decreased body weight and widespread mucosal damage as well as increased IL death as determined by a decreased percentage of viable (PI⁻/ANN⁻, P < 0.005) and increased percentage of necrotic/late apoptotic (PI⁺/ ANN⁺, P < 0.05) and necrotic (PI⁺/ANN⁻, P < 0.05) IL. DSS exposure increased caspase 3 (P < 0.05) and decreased Bcl-2 (P < 0.01) protein levels in mouse IL. Dietary bLf did not influence these cell death outcome measures. However, bLf reduced protein levels of the pro-inflammatory transcription factor, NFκB, in IL (P < 0.05) and was associated with a 34%, albeit non-significant, reduction in TNF-α relative to non-bLf fed mice. DSS treatment increased apoptosis and necrosis of mouse IL and elevated pro-apoptotic and reduced anti-apoptotic protein levels in these cells. Dietary bLf did not influence necrosis or apoptosis of IL but may provide limited protection in the intestine by affecting the pro-inflammatory transcription factor NFκB, and potentially, cytokine expression.

Get full access to this article

View all access options for this article.

References

Brandtzaeg P, Haraldsen G, Rugtveit J. Immunopathology of human inflammatory bowel disease. Springer Semin Immunopathol 18:555–589, 1997.

Podolsky DK. Inflammatory bowel disease. N Engl J Med 347:417–429, 2002.

MacDermott RP. Alterations of the mucosal immune system in inflammatory bowel disease. J Gastroenterol 31:907–916, 1996.

Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69:238–249, 1993.

Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98:694–702, 1990.

Ni J, Chen SF, Hollander D. Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes. Gut 39:234–241, 1996.

Takizawa H, Asakura H, Sasakawa T, Bannai H, Nomoto M. Immunological studies of the mucosa in colitis induced by sodium dextran sulfate in rats. Adv Exp Med Biol 371B:1383–1387, 1995.

Takizawa H, Shintani N, Natsui M, Sasakawa T, Nakakubo H, Nakajima T, Asakura H. Activated immunocompetent cells in rat colitis mucosa induced by dextran sulfate sodium and not complete but partial suppression of colitis by FK506. Digestion 56:259–264, 1995.

Isaacs KL, Sartor RB, Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 103:1587–1595, 1992.

10.

MacDonald TT, Hutchings P, Choy MY, Murch S, Cooke A. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 81:301–305, 1990.

11.

Egger B, Bajaj-Elliott M, MacDonald TT, Inglin R, Eysselein VE, Büchler MW. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 62:240–248, 2000.

12.

Herfarth H, Brand K, Rath HC, Rogler G, Schölmerich J, Falk W. Nuclear factor-kappa B activity and intestinal inflammation in dextran sulphate sodium (DSS)-induced colitis in mice is suppressed by gliotoxin. Clin Exp Immunol 120:59–65, 2000.

13.

Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol 2:725–734, 2002.

14.

De Vry CG, Prasad S, Komuves L, Lorenzana C, Parham C, Le T, Adda S, Hoffman J, Kahoud N, Garlapati R, Shyamsundar R, Mai K, Zhang J, Muchamuel T, Dajee M, Schryver B, McEvoy LM, Ehrhardt RO. Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis. Gut 56:524–533, 2007.

15.

Vermes I, Haanen C, Reutelingsperger C. Flow cytometry of apoptotic cell death. J Immunol Methods 243:167–190, 2000.

16.

Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol Cancer Res 4:221–233, 2006.

17.

Hoffman-Goetz L, Quadrilatero J, Patel H. Cellular lifespan. In: Mooren FC, Volker K, Eds. Molecular and Cellular Exercise Physiology. Indiana (USA): Human Kinetics Press, Chapter 2: pp19–37, 2005.

18.

Renes IB, Verburg M, Van Nispen DJ, Taminiau JA, Büller HA, Dekker J, Einerhand AW. Epithelial proliferation, cell death, and gene expression in experimental colitis: alterations in carbonic anhydrase I, mucin MUC2, and trefoil factor 3 expression. Int J Colorectal Dis 17: 317–326, 2002.

19.

Spagnuolo PA, Hoffman-Goetz L. Lactoferrin effect on lymphocyte cytokines and apoptotisis is independent of exercise. Med Sci Sports Exerc 40:1013–1021, 2008.

20.

Togawa J, Nagase H, Tanaka K, Inamori M, Nakajima A, Ueno N, Saito T, Sekihara H. Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. J Gastroenterol Hepatol 17:1291–1298, 2002.

21.

Håversen L, Ohlsson BG, Hahn-Zoric M, Hanson LA, Mattsby-Baltzer I. Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B. Cell Immunol 220:83–95, 2002.

22.

Spagnuolo PA, Bird RP, Hoffman-Goetz L. Effect of short-term dietary intake of bovine lactoferrin on intestinal lymphocyte apoptosis in healthy mice. Nutrition 23:812–817, 2007.

23.

Shoji H, Oguchi S, Shinohara K, Shimizu T, Yamashiro Y. Effects of iron-unsaturated human lactoferrin on hydrogen peroxide-induced oxidative damage in intestinal epithelial cells. Pediatr Res 61:89–92, 2007.

24.

Naito Y, Takagi T, Handa O, Ishikawa T, Nakagawa S, Yamaguchi T, Yoshida N, Minami M, Kita M, Imanishi J, Yoshikawa T. Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice. J Gastroenterol Hepatol 18:560–569, 2003.

25.

Håversen LA, Baltzer L, Dolphin G, Hanson LA, Mattsby-Baltzer I. Anti-inflammatory activities of human lactoferrin in acute dextran sulphate-induced colitis in mice. Scand J Immunol 57:2–10, 2003.

26.

Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107:1643–1652, 1994.

27.

Togawa J, Nagase H, Tanaka K, Inamori M, Umezawa T, Nakajima A, Naito M, Sato S, Saito T, Sekihara H. Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. Am J Physiol 283:G187–195, 2002.

28.

Naito Y, Takagi T, Ishikawa T, Handa O, Matsumoto N, Yagi N, Matsuyama K, Yoshida N, Yoshikawa T. The inducible nitric oxide synthase inhibitor ONO-1714 blunts dextran sulfate sodium colitis in mice. Eur J Pharmacol 412:91–99, 2001.

29.

Van Cruchten S, Van Den Broeck W. Morphological and biochemical aspects of apoptosis, oncosis and necrosis. Anat Histol Embryol 31: 214–223, 2002.

30.

Mader JS, Richardson A, Salsman J, Top D, de Antueno R, Duncan R, Hoskin DW. Bovine lactoferricin causes apoptosis in Jurkat T-leukemia cells by sequential permeabilization of the cell membrane and targeting of mitochondria. Exp Cell Res 313:2634–2650, 2007.

31.

Wang WP, Iigo M, Sato J, Sekine K, Adachi I, Tsuda H. Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin. Jpn J Cancer Res 91:1022–1027, 2000.

32.

Melgar S, Drmotova M, Rehnström E, Jansson L, Michaëlsson E. Local production of chemokines and prostaglandin E2 in the acute, chronic and recovery phase of murine experimental colitis. Cytokine 35:275–283, 2006.

33.

Da Silva AP, Pollett A, Rittling SR, Denhardt DT, Sodek J, Zohar R. Exacerbated tissue destruction in DSS-induced acute colitis of OPN-null mice is associated with downregulation of TNF-alpha expression and non-programmed cell death. J Cell Physiol 208:629–639, 2006.

34.

Fritsch Fredin M, Elgbratt K, Svensson D, Jansson L, Melgar S, Hultgren Hörnquist E. Dextran sulfate sodium-induced colitis generates a transient thymic involution—impact on thymocyte Subsets. Scand J Immunol 65:421–429, 2007.

35.

Forsberg G, Hernell O, Hammarström S, Hammarström ML. Concomitant increase of IL-10 and pro-inflammatory cytokines in intraepithelial lymphocyte subsets in celiac disease. Int Immunol 19: 993–1001, 2007.